Select Bibliography

Filter by any of these (after searching):

Smith, Ellen M. Lavoie

AUTHOR ABSTRACT DEADLINES

A meeting abstract must be submitted by the first or corresponding author to the Alliance Publications Coordinator (publications@AllianceNCTN.org) at least two weeks prior to the meeting abstract submission deadline. For detailed information about Alliance Publications guidelines, please refer to the policies, along with the author abstract deadlines.

There are 6 items

Clinical course of patients with oxaliplatin-associated neuropathy: N08CB (Alliance)

Pachman, Deirdre R. , Qin, Rui , Seisler, Drew K. ... - ASCO - J Clin Oncol - 2014

Abstract - Secondary - Primary - Symptom Inter - NCCTG-N08CB

A Comparison of the Natural History of Oxaliplatin- and Paclitaxel-Induced Neuropathy (NCCTG N08C1, N08CB/Alliance)

Ruddy, Kathryn Jean , Pachman, Dierdre , Qin, Rui , Seisler, Drew K. ... - ASCO - J Clin Oncol - 2015

Abstract - Primary - Primary - Symptom Inter - Alliance-A151505 , NCCTG-N08C1 , NCCTG-N08CB

Patient-Targeted Education (ePRO-E) to Increase ePRO Uptake Within an Alliance Clinical Trial (A221805-SI1)

Smith, Ellen M. Lavoie , Cho, Youmin , Hillman, Shauna ... - ONS - JNCI Cancer Spectrum - 2024

Abstract - Secondary-not-in-original - Primary - Symptom Inter - Alliance-A221805

CALGB 170601: A phase III double blind trial of duloxetine to treat painful chemotherapy-induced peripheral neuropathy (CIPN)

Smith, Ellen M. Lavoie , Pang, Herbert , Cirrincione, Constance ... - ASCO - J Clin Oncol - 2012

Abstract - Primary - Primary - Onc Nursing - CALGB-170601

Rasch model-based testing of the European Organisation for Research and Treatment of Cancer (EORTC) Quality of Life Questionnaire–Chemotherapy-Induced Peripheral Neuropathy (QLQ-CIPN20) using Alliance for Clinical Trials in Oncology (Alliance) A151408 study data

Smith, Ellen M. Lavoie , Zanville, Noah , Kanzawa-Lee, Grace ... - - Support Care Cancer - 2019

Manuscript - Primary - Primary - Symptom Inter - Alliance-A151408 , NCCTG-N06CA , NCCTG-N08C1 , NCCTG-N08CA , NCCTG-N08CB

Temporal, Location- and Symptom-Specific Likelihood of Patient-Reported Sensory Symptoms Related to Oxaliplatin-Induced Peripheral Neuropathy (OIPN) in Patients Receiving Oxaliplatin for Three Months

Zahrieh, David , Satele, Daniel , Smith, Ellen M. Lavoie ... - - Cancers (Basel) - 2022

Manuscript - Secondary-not-in-original - Primary - SDMC NOS - Alliance-A152116 , NCCTG-N08CB , MC11C4